Development of CNS metastases in breast cancer patients treated with curative intent: a case-control study.

Q1 Medicine
CNS Oncology Pub Date : 2020-09-01 Epub Date: 2020-09-18 DOI:10.2217/cns-2020-0012
Katherine Chakrabarti, Leigh K Swartz, Anoop Gill, Fang Fang, Kelley M Kidwell, Aki Morikawa
{"title":"Development of CNS metastases in breast cancer patients treated with curative intent: a case-control study.","authors":"Katherine Chakrabarti,&nbsp;Leigh K Swartz,&nbsp;Anoop Gill,&nbsp;Fang Fang,&nbsp;Kelley M Kidwell,&nbsp;Aki Morikawa","doi":"10.2217/cns-2020-0012","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> The aim of this study was to identify risk factors that may predispose breast cancer patients to the development of CNS metastases. <b>Materials & methods:</b> We conducted a matched case-control study of breast cancer patients treated with surgery with curative intent. A total of 71 cases and 71 controls were analyzed, matched by year of surgery. <b>Results:</b> In our multivariable model, positive lymph node status (odds ratio [OR]: 5.08; CI: 2.04-12.65), the use of neoadjuvant chemotherapy (OR: 6.02; CI: 2.06-17.57) and triple-negative breast cancer (OR: 5.44; CI: 1.99-14.90) were statistically significant predictors of the development of CNS metastases. <b>Conclusion:</b> Women with certain risk factors have an increased odds of developing CNS metastases and evaluation of utility in brain metastases screening should be considered.</p>","PeriodicalId":10469,"journal":{"name":"CNS Oncology","volume":"9 3","pages":"CNS61"},"PeriodicalIF":0.0000,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/cns-2020-0012","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/cns-2020-0012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/9/18 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 4

Abstract

Background: The aim of this study was to identify risk factors that may predispose breast cancer patients to the development of CNS metastases. Materials & methods: We conducted a matched case-control study of breast cancer patients treated with surgery with curative intent. A total of 71 cases and 71 controls were analyzed, matched by year of surgery. Results: In our multivariable model, positive lymph node status (odds ratio [OR]: 5.08; CI: 2.04-12.65), the use of neoadjuvant chemotherapy (OR: 6.02; CI: 2.06-17.57) and triple-negative breast cancer (OR: 5.44; CI: 1.99-14.90) were statistically significant predictors of the development of CNS metastases. Conclusion: Women with certain risk factors have an increased odds of developing CNS metastases and evaluation of utility in brain metastases screening should be considered.

以治愈为目的治疗的乳腺癌患者中枢神经系统转移的发展:一项病例对照研究。
背景:本研究的目的是确定可能使乳腺癌患者易发生中枢神经系统转移的危险因素。材料与方法:我们对接受手术治疗的乳腺癌患者进行了配对病例对照研究。共分析了71例病例和71例对照,并按手术年份进行匹配。结果:在我们的多变量模型中,淋巴结阳性状态(优势比[OR]: 5.08;CI: 2.04-12.65),使用新辅助化疗(OR: 6.02;CI: 2.06-17.57)和三阴性乳腺癌(OR: 5.44;CI: 1.99-14.90)是中枢神经系统转移发生的统计学显著预测因子。结论:具有某些危险因素的女性发生中枢神经系统转移的几率增加,应考虑评估脑转移筛查的效用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CNS Oncology
CNS Oncology Medicine-Neurology (clinical)
CiteScore
3.80
自引率
0.00%
发文量
12
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信